Related Experiment Video
Updated: Apr 23, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Preoperative low-dose steroid can prevent respiratory insufficiency after thymectomy in generalized myasthenia gravis
Hiroshi Kataoka1, Takao Kiriyama, Takeshi Kawaguchi
1Department of Neurology, Nara Medical University, Kashihara, Nara, Japan.
Background:
Postoperative respiratory insufficiency (PRI) in myasthenia gravis (MG) often occurs within several days after thymectomy and remains problematic. In limited studies reporting that preoperative steroids prevented PRI in patients with MG, high doses of steroids were used and detailed information on the use of steroids is limited. Because high-dose steroids significantly increase the risk of adverse effects, we studied 37 patients with generalized MG to investigate whether low-dose steroids might prevent PRI.
Methods:
The low-dose steroids were started orally, and the dose was gradually increased to the maximum level (30 mg/day). Immediately before thymectomy, patients received the maximum dose of oral steroids daily. PRI was defined as the development of restrictive dysfunction requiring mechanical ventilation within 3 days after thymectomy and total postoperative mechanical ventilation support time of >24 h.
Results:
The rate of PRI in the low-dose steroid use group was significantly lower than that in the no-steroid use group. The postoperative stay in the intensive care unit was shorter in the steroid use group.
Conclusions:
Extended thymectomy is a well-accepted surgical treatment for selected patients with MG. However, PRI remains problematic. Our results suggest that not only preoperative high-dose steroid treatment, but also low-dose steroid treatment can prevent PRI.
Insights
Low-dose steroids can prevent postoperative respiratory insufficiency (PRI) in myasthenia gravis (MG) patients undergoing thymectomy. This approach reduces PRI rates and shortens intensive care unit stays, offering a safer alternative to high-dose treatments.
Area of Science:
- Neurosurgery
- Immunology
- Pharmacology
Background:
- Postoperative respiratory insufficiency (PRI) is a significant complication following thymectomy in myasthenia gravis (MG) patients.
- Previous studies suggest high-dose steroids may prevent PRI, but detailed information and safety concerns exist.
- The risk of adverse effects from high-dose steroids necessitates investigation into alternative preventive strategies.
Purpose of the Study:
- To investigate the efficacy of low-dose steroid treatment in preventing PRI after thymectomy in generalized MG patients.
- To compare the incidence of PRI in patients receiving low-dose steroids versus those not receiving steroids.
- To assess the impact of low-dose steroid use on postoperative intensive care unit (ICU) stay.
Main Methods:
- A study involving 37 patients with generalized MG undergoing thymectomy.
- Oral low-dose steroids were administered, with the dose gradually increased to a maximum of 30 mg/day before surgery.
- PRI was defined by the need for mechanical ventilation within 3 days post-thymectomy and a total ventilation time exceeding 24 hours.
Main Results:
- The rate of PRI was significantly lower in the group receiving low-dose steroids compared to the no-steroid group.
- Patients treated with low-dose steroids had a shorter postoperative stay in the intensive care unit.
- Low-dose steroid administration demonstrated a preventative effect on PRI.
Conclusions:
- Extended thymectomy is a standard treatment for selected MG patients, but PRI remains a concern.
- Low-dose steroid treatment, similar to high-dose regimens, can effectively prevent PRI after thymectomy.
- This finding suggests a safer therapeutic option for managing perioperative risks in MG patients.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:31Skeletal Muscle Relaxants: Therapeutic Uses